Trump Adds to Wealth With Moderna Stock Gains: Here’s How Much President Made
In brief
Moderna’s Phase 3 win fuels a 100%+ stock rally, boosting President Trump’s blind‑trust holdings by up to $91k and underscoring the biotech sector’s growth prospects amid political scrutiny.